| Ident. | Authors (with country if any) | Title |
|---|
| 000030 (2017) |
Vincent Meininger [France] ; Angela Genge [Canada] ; Leonard H. Van Den Berg [Pays-Bas] ; Wim Robberecht [Belgique] ; Albert Ludolph [Allemagne] ; Adriano Chio [Italie] ; Seung H. Kim [Corée du Sud] ; P Nigel Leigh [Royaume-Uni] ; Matthew C. Kiernan [Australie] ; Jeremy M. Shefner [États-Unis] ; Claude Desnuelle [France] ; Karen E. Morrison [Royaume-Uni] ; Susanne Petri [Allemagne] ; Diane Boswell [Royaume-Uni] ; Jane Temple [Royaume-Uni] ; Rajat Mohindra [Royaume-Uni] ; Matt Davies [Royaume-Uni] ; Jonathan Bullman [Royaume-Uni] ; Paul Rees [Royaume-Uni] ; Arseniy Lavrov [Royaume-Uni] | Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial. |
| 000123 (2017) |
Anthony H V. Schapira [Royaume-Uni] ; Susan H. Fox [Canada] ; Robert A. Hauser ; Joseph Jankovic [États-Unis] ; Wolfgang H. Jost [Allemagne] ; Christopher Kenney [États-Unis] ; Jaime Kulisevsky [Espagne] ; Rajesh Pahwa ; Werner Poewe [Autriche] ; Ravi Anand [Suisse] | Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial. |
| 000372 (2016) |
Laleh Golestanirad [États-Unis] ; Behzad Elahi ; Simon J. Graham [Canada] ; Sunit Das [Canada] ; Lawrence L. Wald [États-Unis] | Efficacy and Safety of Pedunculopontine Nuclei (PPN) Deep Brain Stimulation in the Treatment of Gait Disorders: A Meta-Analysis of Clinical Studies. |
| 000430 (2016) |
Francisco A. Ponce ; Wael F. Asaad ; Kelly D. Foote ; William S. Anderson ; G. Rees Cosgrove ; Gordon H. Baltuch [États-Unis] ; Kara Beasley [États-Unis] ; Donald E. Reymers ; Esther S. Oh ; Steven D. Targum ; Gwenn S. Smith [États-Unis] ; Constantine G. Lyketsos [États-Unis] ; Andres M. Lozano [Canada] | Bilateral deep brain stimulation of the fornix for Alzheimer's disease: surgical safety in the ADvance trial. |
| 000507 (2015) |
Janice M. Morse [États-Unis] ; Pierre Gervais [Canada] ; Charlotte Pooler [Canada] ; Andrew Merryweather [États-Unis] ; Alexa K. Doig [États-Unis] ; Donald Bloswick [États-Unis] | The Safety of Hospital Beds |
| 000674 (2015) |
Anthony E. Lang ; Ramon L. Rodriguez ; James T. Boyd ; Sylvain Chouinard ; Cindy Zadikoff ; Alberto J. Espay ; John T. Slevin ; Hubert H. Fernandez ; Mark F. Lew ; David A. Stein ; Per Odin ; Victor S. C. Fung ; Fabian Klostermann ; Alfonso Fasano ; Peter V. Draganov ; Nathan Schmulewitz ; Weining Z. Robieson ; Susan Eaton ; Krai Chatamra ; Janet A. Benesh ; Jordan Dubow | Integrated safety of levodopa‐carbidopa intestinal gel from prospective clinical trials |
| 000742 (2015) |
Eric J. Lenze [États-Unis] ; Benoit H. Mulsant [Canada] ; Daniel M. Blumberger [Canada] ; Jordan F. Karp [États-Unis] ; John W. Newcomer [États-Unis] ; Stewart J. Anderson [États-Unis] ; Mary Amanda Dew [États-Unis] ; Meryl A. Butters [États-Unis] ; Jacqueline A. Stack [États-Unis] ; Amy E. Begley [États-Unis] ; Charles F. Reynolds [États-Unis] | Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial. |
| 000891 (2014) |
Paul S. Myles ; Kate Leslie ; Matthew T V. Chan ; Andrew Forbes ; Philip J. Peyton ; Michael J. Paech ; W Scott Beattie ; Daniel I. Sessler ; P J Devereaux ; Brendan Silbert ; Thomas Schricker ; Sophie Wallace | The safety of addition of nitrous oxide to general anaesthesia in at-risk patients having major non-cardiac surgery (ENIGMA-II): a randomised, single-blind trial. |
| 000A68 (2014) |
Kerri A. Schoedel [Canada] ; Sarah A. Morrow [Royaume-Uni] ; Edward M. Sellers [Canada] | Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect |
| 000C78 (2013) |
Matthew Vonloh [États-Unis] ; Robert Chen [Canada] ; Benzi Kluger [États-Unis] | Safety of Transcranial Magnetic Stimulation in Parkinson’s Disease: A Review of the Literature |
| 000F83 (2013) |
Stewart A. Factor [États-Unis] ; Kenneth Wolski [États-Unis] ; Daniel M. Togasaki [États-Unis] ; Susan Huyck [États-Unis] ; Marc Cantillon [États-Unis] ; T. W. Ho [États-Unis] ; Robert A. Hauser [États-Unis] ; Emmanuelle Pourcher [Canada] | Long‐term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease |
| 001007 (2013) |
K. A. Papp [Canada] ; R. G. Langley [Canada] ; B. Sigurgeirsson [Islande] ; M. Abe [Japon] ; D. R. Baker [États-Unis] ; P. Konno [Estonie] ; S. Haemmerle [Suisse] ; H. J. Thurston [Suisse] ; C. Papavassilis [Suisse] ; H. B. Richards [Suisse] | Efficacy and safety of secukinumab in the treatment of moderate‐to‐severe plaque psoriasis: a randomized, double‐blind, placebo‐controlled phase II dose‐ranging study |
| 001047 (2013) |
Raymond T. Bartus [États-Unis] ; Tiffany L. Baumann [États-Unis] ; Joao Siffert [États-Unis] ; Christopher D. Herzog [États-Unis] ; Ron Alterman [États-Unis] ; Nicholas Boulis [États-Unis] ; Dennis A. Turner [États-Unis] ; Mark Stacy [États-Unis] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; C. Warren Olanow [États-Unis] | Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients |
| 001099 (2012) |
Shubhayan Sanatani [Canada] ; James E. Potts ; John H. Reed ; J Philip Saul ; Elizabeth A. Stephenson ; Karen A. Gibbs ; Charles C. Anderson ; Andrew S. Mackie ; Pamela S. Ro ; Svjetlana Tisma-Dupanovic ; Ronald J. Kanter ; Anjan S. Batra ; Anne Fournier ; Andrew D. Blaufox ; Harinder R. Singh ; Bertrand A. Ross ; Kenny K. Wong ; Yaniv Bar-Cohen ; Brian W. Mccrindle ; Susan P. Etheridge | The study of antiarrhythmic medications in infancy (SAMIS): a multicenter, randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants. |
| 001315 (2012) |
Bruno Dubois [France] ; Eduardo Tolosa [Espagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew J. Lees [Royaume-Uni] ; Günther Schumann [Allemagne] ; Emmanuelle Pourcher [Canada] ; Julian Gray [Suisse] ; Gail Thomas [Royaume-Uni] ; Jina Swartz [Royaume-Uni] ; Timothy Hsu [États-Unis] ; Margaret L. Moline [États-Unis] | Donepezil in Parkinson's disease dementia: A randomized, double‐blind efficacy and safety study |
| 001F83 (2009) |
P J Mease [États-Unis] ; K. Hobbs [États-Unis] ; A. Chalmers [Canada] ; H. El-Gabalawy [Canada] ; A. Bookman [Canada] ; E. Keystone [Canada] ; D E Furst [États-Unis] ; P. Anklesaria [États-Unis] ; A E Heald [États-Unis] | Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor α antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study |
| 002067 (2009) |
P. A. Guertin [Canada] ; C. Brochu [Canada] | Preliminary evidence of safety following administration of L-DOPA and buspirone in an incomplete monoplegic patient |
| 002645 (2007) |
A. Jon Stoessl [Canada] ; Michael G. Kaplitt [États-Unis] ; Andrew Feigin [États-Unis] ; Chengke Tang [États-Unis] ; Helen L. Fitzsimons ; Paul Mattis [États-Unis] ; Patricia A. Lawlor [Nouvelle-Zélande] ; Ross J. Bland ; Deborah Young [Nouvelle-Zélande] ; Kristin Strybing [États-Unis] ; David Eidelberg [États-Unis] ; Matthew J. During [États-Unis, Nouvelle-Zélande] | Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease : an open label, phase I trial. Commentary |
| 002951 (2005) |
Fabrizio Drago [Italie] ; Antonella De Santis ; Giorgia Grutter ; Massimo S. Silvetti | Transvenous cryothermal catheter ablation of re-entry circuit located near the atrioventricular junction in pediatric patients: efficacy, safety, and midterm follow-up. |
| 002C23 (2004) |
Allan C. Skanes ; Douglas L. Jones ; Patrick Teefy ; Colette Guiraudon [Canada] ; Raymond Yee ; Andrew D. Krahn ; George J. Klein | Safety and Feasibility of Cryothermal Ablation Within the Mid‐ and Distal Coronary Sinus |
| 002C49 (2004) |
Jacqueline Low [Canada] | Managing Safety and Risk: The Experiences of People with Parkinson’s Disease who Use Alternative and Complementary Therapies |
